ABSTRACT
Objectives Various individual factors have been shown to influence Covid-19 mortalities, but these factors do not exist in isolation. Unique to this study is a multivariate approach that has yet to be fully explored by previous research. Using an interconnected multifactor model, this work investigated social determinant, geographic, prior health, and political behavioral factors likely to influence Covid-19 per capita fatalities in Texas.
Methods County-level income, rurality, insurance, health status, 2020 presidential vote percentage, and fatality rate data were collected and analyzed in a path analysis model with Covid-19 per capita fatalities as the key variable of interest.
Results The analysis found strong support for the proposed model structure (R2 = 37.6%). The strongest overall effects on the Covid-19 per capita fatality rate came from income levels and voting behaviors.
Conclusion The model explained a substantial amount of variability in mortalities attributed to Covid-19. Socioeconomic and political factors provided the strongest contribution to the per-capita Covid-19 death rate, controlling for the other variables studied. The Covid-19 pandemic was highly politicized by various leaders and media outlets. The current analysis showed that political trends were one of the key overall factors related to Covid-19 mortality. The strongest overall factor was median income. Income is used to enhance one’s current health or acquire adequate treatment which may safeguard people from the most severe effects of Covid-19. Counties with lower income levels had higher rates of Covid-19 per capita fatalities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was unfunded.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB approval was necessary as this was a study that only used online publicly available data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.